CAT vs TCRX · P/E 48, rev $37.96B vs rev $2.0M
Caterpillar Inc (CAT) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the CAT and TCRX stock pages for the full models.
Not investment advice.